First in Human Study in Subjects With Obesity, But Otherwise Healthy

Inclusion criteria

• . Willing and able to provide informed consent prior to initiation of any study specific procedures/activities.
• . Males and females ≥18 to \<=65 years of age, at the time of signing informed consent, who have been diagnosed with obesity, defined by BMI.
• . Except for obesity, otherwise healthy or with stable, well controlled obesity-related conditions as determined by the investigator based on a medical evaluation including physical exam, medical history, laboratory tests, and ECGs.
• . Body mass index (BMI) ≥ 30.0 kg/m2 to 45.0 kg/m2 (Obesity to be confirmed by Caliper test showing body fat percentage with the average or above the average level).
• . Has maintained a stable body weight during the 3 months prior to Screening (\<5% body weight change).
• . Willing to maintain current diet and physical activity regimen.
• . Females must be of non-reproductive potential:
• . Males must agree to practice an acceptable method of effective birth control while on study through 5 half-lives plus one week after receiving last dose of DA-1726. Acceptable methods of birth control include:

Exclusion criteria